National Medical Care Co., providing medical services and operation and management of hospitals, reported SAR 92.5m net profit at the end of 2013, a 12% decrease compared to last year, as shown in the following table:
| Item | 2012 | 2013 | Change |
|---|---|---|---|
| Revenues | 524.75 | 586.28 | 11.7 % |
| Gross Income | 135.13 | 130.06 | (3.8 %) |
| Operating Income | 104.01 | 91.55 | (12.0 %) |
| Net Income | 104.96 | 92.50 | (11.9 %) |
| Average Shares | 44.85 | 44.85 | - |
| Earnings Per Share before unusual items (Riyals) | 2.34 | 2.06 | (11.9 %) |
| EPS (Riyal) | 2.34 | 2.06 | (11.9 %) |
| Item | Q4 2012 | Q4 2013 | Change |
|---|---|---|---|
| Revenues | 137.61 | 164.16 | 19.3 % |
| Gross Income | 31.93 | 33.54 | 5.0 % |
| Operating Income | 23.24 | 21.42 | (7.8 %) |
| Net Income | 25.03 | 20.39 | (18.6 %) |
| Average Shares | 44.85 | 44.85 | - |
| Earnings Per Share before unusual items (Riyal) | 0.56 | 0.45 | (18.6 %) |
| EPS (Riyal) | 0.56 | 0.45 | (18.6 %) |
| Period | Revenues | Change | Gross Income | Change | Operating Income | Change |
|---|---|---|---|---|---|---|
| Q1 2013 | 145.36 | 12.8 % | 38.75 | 9.0 % | 31.05 | 8.0 % |
| Q2 2013 | 142.20 | 3.6 % | 31.78 | (15.5 %) | 21.64 | (28.8 %) |
| Q3 2013 | 134.56 | 11.2 % | 24.08 | (19.9 %) | 17.45 | (19.3 %) |
| Q4 2013 | 164.16 | 19.3 % | 33.54 | 5.0 % | 21.42 | (7.8 %) |
| 2013 | 586.28 | 11.7 % | 130.06 | (3.8 %) | 91.55 | (12.0 %) |
| Period | Net Income | Change | EPS(Riyal) | Extraordinary Income/Expense | Net Profit Before Unusual Items | EPS(Riyal) |
|---|---|---|---|---|---|---|
| Q1 2013 | 31.12 | 7.8 % | 0.69 | - | 31.12 | 0.69 |
| Q2 2013 | 22.19 | (25.0 %) | 0.49 | - | 22.19 | 0.49 |
| Q3 2013 | 18.80 | (12.4 %) | 0.42 | - | 18.80 | 0.42 |
| Q4 2013 | 20.39 | (18.6 %) | 0.45 | - | 20.39 | 0.45 |
| 2013 | 92.50 | (11.9 %) | 2.06 | - | 92.50 | 2.06 |
| Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
|---|---|---|---|
| Q1 2012 | 25.88 % | 25.84 % | 20.09 % |
| Q2 2012 | 25.57 % | 25.38 % | 19.54 % |
| Q3 2012 | 25.99 % | 25.46 % | 19.56 % |
| Q4 2012 | 25.75 % | 25.14 % | 20.00 % |
| 2012 | 25.75 % | 25.14 % | 20.00 % |
| Q1 2013 | 25.56 % | 24.89 % | 19.81 % |
| Q2 2013 | 24.27 % | 23.17 % | 18.27 % |
| Q3 2013 | 22.61 % | 21.99 % | 17.36 % |
| Q4 2013 | 21.86 % | 20.98 % | 15.78 % |
| 2013 | 22.18 % | 20.98 % | 15.78 % |
| Period | Shares Outstanding (M) | EPS (Riyal) | Earnings Per Share before unusual items (Riyal) | Book Value (BV) |
|---|---|---|---|---|
| Q1 2013 | 44.85 | 2.39 | 2.39 | 18.19 |
| Q2 2013 | 44.85 | 2.23 | 2.23 | 17.24 |
| Q3 2013 | 44.85 | 2.17 | 2.17 | 17.65 |
| Q4 2013 | 44.85 | 2.06 | 2.06 | 18.11 |
| Period | P/E | Recurring P/E | Price/book |
|---|---|---|---|
| Q1 2013 | 30.02 | 30.02 | 3.94 |
| Q2 2013 | 26.07 | 26.07 | 3.37 |
| Q3 2013 | 25.16 | 25.16 | 3.09 |
| Q4 2013 | 26.43 | 26.43 | 3.01 |
Q4 2013
| Period | Medical Services | Pharmacies |
|---|---|---|
| Q1 2013 | 117.72 | 27.65 |
| Q2 2013 | 115.21 | 26.98 |
| Q3 2013 | 109.28 | 25.28 |
| Q4 2013 | 134.04 | 30.12 |
| Current | |
| Market Cap (M Riyal) | 6,005.42 |
| Enterprise Value (EV) (M Riyal) | 5,890.87 |
| Shares Outstanding ((M)) | 44.85 |
| EPS ( Riyal) (TTM) | 7.46 |
| Book Value (BV) ( Riyal) | 39.86 |
| Par Value ( Riyal) | 10.00 |
| Recurring P/E | 20.54 |
| P/E (TTM) | 17.94 |
| Price/book | 3.36 |
| Return on Average Assets (%) (TTM) | 13.9 |
| Return on Average Equity (%) (TTM) | 20.1 |
| EV/adj EBITDA | 13.97 |
| EV/Revenues | 3.76 |
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}